DE60328676D1 - Formulierung eines gemisches aus flavonoiden und flavanen mit freiem b ring als therapeutisches mittel - Google Patents
Formulierung eines gemisches aus flavonoiden und flavanen mit freiem b ring als therapeutisches mittelInfo
- Publication number
- DE60328676D1 DE60328676D1 DE60328676T DE60328676T DE60328676D1 DE 60328676 D1 DE60328676 D1 DE 60328676D1 DE 60328676 T DE60328676 T DE 60328676T DE 60328676 T DE60328676 T DE 60328676T DE 60328676 D1 DE60328676 D1 DE 60328676D1
- Authority
- DE
- Germany
- Prior art keywords
- cox
- present
- mixture
- free
- lipoxygenase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37716802P | 2002-04-30 | 2002-04-30 | |
PCT/US2003/013463 WO2003092599A2 (en) | 2002-04-30 | 2003-04-30 | Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60328676D1 true DE60328676D1 (de) | 2009-09-17 |
Family
ID=29401452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60328676T Expired - Lifetime DE60328676D1 (de) | 2002-04-30 | 2003-04-30 | Formulierung eines gemisches aus flavonoiden und flavanen mit freiem b ring als therapeutisches mittel |
Country Status (16)
Country | Link |
---|---|
US (5) | US7514469B2 (de) |
EP (2) | EP2108370A1 (de) |
JP (2) | JP4723239B2 (de) |
KR (1) | KR100621234B1 (de) |
CN (2) | CN100544715C (de) |
AT (1) | ATE438393T1 (de) |
AU (1) | AU2003228777C1 (de) |
BR (1) | BRPI0309689B1 (de) |
CA (2) | CA2484192C (de) |
DE (1) | DE60328676D1 (de) |
DK (1) | DK1503778T3 (de) |
ES (1) | ES2330097T3 (de) |
HK (2) | HK1073247A1 (de) |
NZ (1) | NZ535988A (de) |
RU (1) | RU2379031C2 (de) |
WO (1) | WO2003092599A2 (de) |
Families Citing this family (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7108868B2 (en) | 2002-03-22 | 2006-09-19 | Unigen Pharmaceuticals, Inc. | Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
US7972632B2 (en) | 2003-02-28 | 2011-07-05 | Unigen Pharmaceuticals, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
NZ535988A (en) | 2002-04-30 | 2005-09-30 | Unigen Pharmaceuticals Inc | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
US8034387B2 (en) | 2002-04-30 | 2011-10-11 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
US8945518B2 (en) | 2002-04-30 | 2015-02-03 | Unigen, Inc. | Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions |
US20040097429A1 (en) * | 2002-11-18 | 2004-05-20 | Nieuwenhuizen Arie Gijsbert | Method for the reduction of the mammalian appetite |
CA2516710A1 (en) * | 2003-02-26 | 2004-09-10 | Unigen Pharmaceuticals, Inc. | Formulation for use in the prevention and treatment of carbohydrate induced diseases and conditions |
CA2521429A1 (en) | 2003-04-04 | 2004-10-21 | Unigen Pharmaceuticals, Inc. | Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care |
JP2007502288A (ja) | 2003-08-12 | 2007-02-08 | スリーエム イノベイティブ プロパティズ カンパニー | オキシム置換イミダゾ含有化合物 |
EP1658076B1 (de) | 2003-08-27 | 2013-03-06 | 3M Innovative Properties Company | Aryloxy- und arylalkylenoxy-substituierte imidazochinoline |
RU2392957C2 (ru) * | 2003-09-02 | 2010-06-27 | Юниджен Фармасьютиклз, Инк. | Композиция, содержащая смесь флавоноидов со свободным кольцом и флаванов, которая предназначена для предупреждения и лечения ухудшения когнитивной способности и связанных с возрастом ослаблений памяти |
AU2004270201A1 (en) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Treatment for CD5+ B cell lymphoma |
US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
BRPI0414856A (pt) | 2003-10-03 | 2006-11-21 | 3M Innovative Properties Co | imidazoquinolinas alcóxi-substituìdas |
CA2545774A1 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Oxime substituted imidazo ring compounds |
WO2005048945A2 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo ring compounds |
US8691837B2 (en) | 2003-11-25 | 2014-04-08 | 3M Innovative Properties Company | Substituted imidazo ring systems and methods |
WO2005066170A1 (en) | 2003-12-29 | 2005-07-21 | 3M Innovative Properties Company | Arylalkenyl and arylalkynyl substituted imidazoquinolines |
US8735421B2 (en) | 2003-12-30 | 2014-05-27 | 3M Innovative Properties Company | Imidazoquinolinyl sulfonamides |
WO2005094531A2 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
WO2005117608A1 (en) | 2004-06-04 | 2005-12-15 | Horizon Science Pty Ltd | Natural sweetener |
WO2005123080A2 (en) | 2004-06-15 | 2005-12-29 | 3M Innovative Properties Company | Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
WO2006009826A1 (en) | 2004-06-18 | 2006-01-26 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
WO2006038923A2 (en) | 2004-06-18 | 2006-04-13 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
WO2006065280A2 (en) | 2004-06-18 | 2006-06-22 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods |
KR100610562B1 (ko) * | 2004-06-28 | 2006-08-08 | 재단법인서울대학교산학협력재단 | 플라보노이드 유도체를 포함하는 급성 또는 만성 퇴행성뇌질환의 예방 또는 치료용 조성물 |
KR100545304B1 (ko) * | 2004-09-01 | 2006-05-08 | 주식회사 유니젠 | 아선약을 포함하는 운카리아 속 식물, 또는 이의 황금및/또는 녹차의 배합물을 포함하는 사이클로옥시게나제및/또는 5-리폭시게나제 억제용 조성물 |
EP1796656A2 (de) * | 2004-09-17 | 2007-06-20 | Oystershell NV | Zusammensetzung zur unterdrückung oder prävention der bildung eines biofilms |
TW200630102A (en) * | 2004-10-19 | 2006-09-01 | Unigen Pharmaceuticals Inc | Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions |
CN101141999A (zh) * | 2004-12-22 | 2008-03-12 | 高露洁-棕榄公司 | 含有类黄酮和黄烷的口腔护理组合物 |
US20060140881A1 (en) | 2004-12-22 | 2006-06-29 | Guofeng Xu | Oral care compositions containing flavonoids and flavans |
WO2006074003A2 (en) | 2004-12-30 | 2006-07-13 | 3M Innovative Properties Company | CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS |
CA2594674C (en) | 2004-12-30 | 2016-05-17 | 3M Innovative Properties Company | Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
US9248127B2 (en) | 2005-02-04 | 2016-02-02 | 3M Innovative Properties Company | Aqueous gel formulations containing immune response modifiers |
US7968563B2 (en) | 2005-02-11 | 2011-06-28 | 3M Innovative Properties Company | Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods |
JP4823538B2 (ja) * | 2005-02-28 | 2011-11-24 | 株式会社mimozax | アカシア属樹皮由来物を含有する抗肥満組成物 |
EP2444093A1 (de) * | 2005-03-10 | 2012-04-25 | Unigen, Inc. | Formulierung einer Mischung aus Flavonoiden mit freiem B-Ring und Flavanen als Therapiemittel |
EP1869043A2 (de) | 2005-04-01 | 2007-12-26 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridin-1,4-diamine und analoge davon |
AU2006232375A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
WO2006128259A1 (en) | 2005-06-03 | 2006-12-07 | Horizon Science Pty Ltd | Substances having body mass redistribution properties |
KR100729731B1 (ko) | 2005-07-19 | 2007-06-20 | 건국대학교 산학협력단 | 사람 피부 세포의 세포사멸을 억제하는 활성을 갖는플라보노이드 |
CA2627953A1 (en) * | 2005-11-01 | 2007-05-10 | Mars, Incorporated | Flavanols and b-type procyanidins and inflammation |
JP2009518439A (ja) * | 2005-12-09 | 2009-05-07 | メタプロテオミクス,エルエルシー | ホップ及びアカシア産物によるプロテインキナーゼ調節 |
US20070140990A1 (en) | 2005-12-21 | 2007-06-21 | Nataly Fetissova | Oral Compositions Comprising Propolis |
WO2007108042A1 (ja) * | 2006-03-15 | 2007-09-27 | Tropical Technology Center Ltd. | 抗炎症剤 |
US20080003300A1 (en) * | 2006-06-30 | 2008-01-03 | Gaffar Maria C | Compostions containing Mg/Zn/F-CaP plus inhibitors of pro-inflammatory Cytokines (a combination of a Free-B-Ring flavonoids and a flavan) for osteoporosis prevention, therapy and treatment of bone diseases |
US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
US9682256B2 (en) * | 2006-07-14 | 2017-06-20 | Colgate-Palmolive Company | Methods of making compositions comprising films |
BRPI0621960A2 (pt) | 2006-08-10 | 2011-12-27 | Wood One Co Ltd | composiÇço hipoglicÊmica contendo derivado da casca de acÁcia |
WO2008018141A1 (en) | 2006-08-10 | 2008-02-14 | Wood One Co., Ltd. | Composition for preventing and/or treating itching containing component originating in the bark of tree belonging to the genus acacia |
EP2052732A4 (de) | 2006-08-10 | 2012-03-21 | Mimozax Co Ltd | Antioxidans-zusammensetzung mit einem bestandteil aus der rinde des baums des genus akazie |
WO2008018139A1 (en) * | 2006-08-10 | 2008-02-14 | Wood One Co., Ltd. | Antiobesity composition containing component originating in the bark of tree belonging to the genus acacia |
WO2008018140A1 (en) * | 2006-08-10 | 2008-02-14 | Wood One Co., Ltd. | Composition for preventing and/or treating tumor containing component originating in the bark of tree belonging to the genus acacia |
CN101553582A (zh) * | 2006-09-19 | 2009-10-07 | 视界科技有限公司 | 从甘蔗中获得的提取物及其生产方法 |
KR100761248B1 (ko) * | 2006-10-12 | 2007-10-04 | 주식회사 유니젠 | 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물 |
US8517728B2 (en) | 2007-01-24 | 2013-08-27 | Colgate-Palmolive Company | Oral care implement having fluid delivery system |
WO2008131119A2 (en) * | 2007-04-17 | 2008-10-30 | Acropolis Pharmaceuticals, Inc. | Composition and method for cancer treatment and prevention |
MX2010004647A (es) * | 2008-02-08 | 2010-06-07 | Colgate Palmolive Co | Producto para cuidado oral y metodos de uso del mismo. |
BRPI0822340A2 (pt) * | 2008-02-25 | 2015-06-16 | Nestec Sa | Composições nutricionais para promoção e manutenção da cartilagem |
TWI366466B (en) * | 2008-05-08 | 2012-06-21 | Ind Tech Res Inst | Herbal extracts capable of inducing immune cells to produce interferon and activating toll-like receptors and the preparation thereof |
WO2010085811A2 (en) * | 2009-01-26 | 2010-07-29 | Taipei Medical University | Use of pterosin compounds for treating diabetes and obesity |
MY198422A (en) | 2009-04-29 | 2023-08-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
KR101582907B1 (ko) * | 2010-10-27 | 2016-01-08 | 주식회사 성균바이오텍 | 등골나물속 추출물을 유효성분으로 하는 비만 또는 골대사질환 예방 또는 치료용 조성물 |
EP2672832B1 (de) | 2011-02-08 | 2020-03-25 | The Product Makers (Australia) Pty Ltd | Zuckerextrakte |
MX341247B (es) | 2011-03-09 | 2016-08-12 | Colgate Palmolive Co | Dispositivo de limpieza interdental. |
KR20120132114A (ko) * | 2011-05-27 | 2012-12-05 | 한국생명공학연구원 | 오고닌을 유효성분으로 함유하는 천식 예방 또는 치료용 약학적 조성물 |
JP6203469B2 (ja) * | 2011-06-03 | 2017-09-27 | 花王株式会社 | 歯磨組成物 |
CN102579590A (zh) * | 2012-02-18 | 2012-07-18 | 贾古友 | 一种治疗膝关节骨性关节炎的药物 |
AU2013235422B2 (en) * | 2012-03-19 | 2016-12-15 | Buck Institute For Research On Aging | APP specific BACE inhibitors (ASBIs) and uses thereof |
CN102755311A (zh) * | 2012-07-05 | 2012-10-31 | 吉林大学 | 千层纸素a在制备治疗肺炎药物中的应用 |
AU2013308395C1 (en) | 2012-08-28 | 2018-03-15 | Poly Gain Pte Ltd | Extraction method |
US9171343B1 (en) | 2012-09-11 | 2015-10-27 | Aseko, Inc. | Means and method for improved glycemic control for diabetic patients |
US9897565B1 (en) | 2012-09-11 | 2018-02-20 | Aseko, Inc. | System and method for optimizing insulin dosages for diabetic subjects |
EP2911554B1 (de) | 2012-10-26 | 2017-04-26 | Colgate-Palmolive Company | Mundpflegevorrichtung |
TWI825378B (zh) | 2013-06-17 | 2023-12-11 | 美商優力竟股份有限公司 | 用於關節健康之組合物及方法 |
BR112016002244A2 (pt) * | 2013-08-02 | 2017-08-01 | Council Scient Ind Res | ulmosídeo-a: útil para a prevenção ou cura de doenças metabólicas |
EP3035949B1 (de) | 2013-08-16 | 2023-10-04 | Poly Gain Pte Ltd | Aus zuckerrohr gewonnene extrakte und verwendungen |
US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
US9233204B2 (en) | 2014-01-31 | 2016-01-12 | Aseko, Inc. | Insulin management |
NZ727164A (en) * | 2014-06-16 | 2018-05-25 | Unigen Inc | Compositions and methods for managing or improving bone disorders, cartilage disorders, or both |
US10583161B2 (en) * | 2014-06-16 | 2020-03-10 | Unigen, Inc. | Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof |
CN104083390A (zh) * | 2014-06-28 | 2014-10-08 | 广西大学 | 6,7-二羟基-5-β-D-吡喃葡萄糖-4`-β-O-D-吡喃葡萄糖黄酮在制备抗炎药物中的用途 |
US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
JP6989262B2 (ja) | 2014-10-27 | 2022-01-05 | アセコー インコーポレイテッド | 皮下外来患者管理 |
CN104721210B (zh) * | 2015-03-16 | 2017-10-13 | 中国药科大学 | 千层纸素苷在制备抗肿瘤转移药中的应用 |
JP6858751B2 (ja) | 2015-08-20 | 2021-04-14 | アセコー インコーポレイテッド | 糖尿病管理療法アドバイザ |
CN106727492A (zh) * | 2016-12-22 | 2017-05-31 | 黄冈师范学院 | 一种多甲氧基黄酮在制备治疗皮肤乳头状瘤的药物上的应用 |
JP7209645B2 (ja) * | 2017-06-15 | 2023-01-20 | サミ-サビンサ グループ リミテッド | βセクレターゼの阻害のための組成物および方法 |
EP3737370A4 (de) * | 2018-01-09 | 2021-12-15 | Brigham Young University | Zusammensetzungen und verfahren zur behandlung von schmerzen mit wogonin |
CN108610394B (zh) * | 2018-05-07 | 2021-08-31 | 深圳市维琪医药研发有限公司 | 一种拟肽类化合物的制备纯化方法以及应用 |
CN114617968B (zh) | 2019-04-09 | 2023-10-03 | 北京五和博澳药业股份有限公司 | 黄酮多酚类药物自乳化组合物、其制备方法、药物组合物及用途 |
JP2022550671A (ja) * | 2019-08-26 | 2022-12-05 | サミ-サビンサ グループ リミテッド | 植物活性物質およびその抗汚染効果 |
US20220031654A1 (en) * | 2020-07-30 | 2022-02-03 | Unigen, Inc. | Standardized Bioflavonoid Composition for Regulation of Homeostasis of Host Defense Mechanism |
CN112156120B (zh) * | 2020-11-09 | 2021-11-02 | 中国科学院新疆理化技术研究所 | 一种帚枝香青正丁醇提取物的用途 |
DE202022106782U1 (de) | 2022-12-03 | 2022-12-19 | Mohammed Azeemuddin | Antiurolithiatische, antiosteoporotische, antidiabetische und entzündungshemmende Zusammensetzung eines Polykräuterextraktes |
Family Cites Families (205)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3686872A (en) | 1970-06-30 | 1972-08-29 | Anthony James Whitworth | Soil grouting process |
US3706581A (en) | 1970-10-05 | 1972-12-19 | Borden Co | Soil grouting process and composition |
US4035510A (en) * | 1976-09-15 | 1977-07-12 | Scott Eugene J Van | Treatment of acne utilizing N-methyldiethanolamine |
US4201776A (en) * | 1977-01-31 | 1980-05-06 | The Green Cross Corporation | Food additive for reinforcing foods deficient in fiber content |
GB2024817B (en) | 1978-03-15 | 1982-09-22 | Wellcome Found | Flavan derivatives |
US4268517A (en) * | 1979-08-30 | 1981-05-19 | Continental Pharma | Pharmaceutical composition and therapeutical method for treating degenerative affections of the articular cartilage |
JPS5738721A (en) | 1980-08-20 | 1982-03-03 | Wataru Sakai | Production of bamboo extract having effect for hemorrhoids |
JPS57109720A (en) * | 1980-12-22 | 1982-07-08 | Continentalfuaama | Medicine containing (+)-catechine and/or its salt for degenerated disease of articular gristle |
US4374824A (en) | 1981-01-27 | 1983-02-22 | Krishan Dyal Mathur | Dentifrice |
GB2115409B (en) * | 1982-02-24 | 1985-08-07 | Zyma Sa | Novel crystal modifications of (+)-catechin |
JPS6150921A (ja) | 1984-08-20 | 1986-03-13 | Ichimaru Fuarukosu Kk | バイカリンの精製化法 |
JPS6183179A (ja) | 1984-09-28 | 1986-04-26 | Otsuka Pharmaceut Co Ltd | 新規フラボン誘導体 |
JPS61161219A (ja) | 1985-01-08 | 1986-07-21 | Osaka Chem Lab | アトピ−性皮膚炎症用化粧料組成物 |
JPS61233627A (ja) | 1985-04-10 | 1986-10-17 | Agency Of Ind Science & Technol | 肥満細胞脱顆粒抑制剤 |
JPS61238719A (ja) | 1985-04-17 | 1986-10-24 | Shiseido Co Ltd | 頭髪化粧料 |
JPH0755895B2 (ja) | 1985-08-29 | 1995-06-14 | サンスター株式会社 | 歯磨組成物 |
US4627977A (en) | 1985-09-13 | 1986-12-09 | Colgate-Palmolive Company | Anticalculus oral composition |
JPS6327435A (ja) | 1986-07-18 | 1988-02-05 | Ichimaru Pharcos Co Ltd | バイカレイン高含有エキスの抽出法 |
AU7873187A (en) | 1986-08-08 | 1988-02-24 | University Of Minnesota | Method of culturing leukocytes |
IN168400B (de) * | 1987-01-30 | 1991-03-23 | Colgate Palmolive Co | |
US5156835A (en) * | 1987-01-30 | 1992-10-20 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
CA1308661C (en) | 1987-06-26 | 1992-10-13 | Masayasu Kurono | AGENT FOR INHIBITING BINDING OF 5.alpha.-DIHYDRO-TESTOSTERONE WITH ANDROGEN RECEPTOR AS WELL AS PROCESS FOR OBTAINING SAME |
US5098709A (en) * | 1987-07-21 | 1992-03-24 | Kang Kwon J | Method of administrating a fused salt from natural substances, namely ginkgo, persimmon, pine, and bamboo in the treatment of inflammations |
JPH0662408B2 (ja) | 1987-10-01 | 1994-08-17 | 太陽化学株式会社 | 抗う蝕及び抗歯周病組成物 |
FR2628317B1 (fr) | 1988-03-09 | 1991-11-08 | Lvmh Rech | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant |
US4965067A (en) * | 1988-08-10 | 1990-10-23 | The Proctor & Gamble Company | Oral compositions |
US4942333A (en) | 1988-12-05 | 1990-07-17 | North American Philips Corporation | Shadow mask with border pattern |
JPH0755895Y2 (ja) | 1989-04-04 | 1995-12-25 | 函館製網船具株式会社 | 多段式養殖籠 |
US4946684A (en) | 1989-06-20 | 1990-08-07 | American Home Products Corporation | Fast dissolving dosage forms |
FR2651132B1 (fr) * | 1989-08-30 | 1993-01-08 | Pacific Chem Co Ltd | Agents de protection des cellules contre les especes chimiques a oxygene actif et leur preparation. |
JPH03240725A (ja) | 1990-02-15 | 1991-10-28 | Senjiyu Seiyaku Kk | メイラード反応阻害剤 |
JPH03251518A (ja) | 1990-02-26 | 1991-11-11 | Ichimaru Pharcos Co Ltd | 竹から抽出されたフケ菌発育阻害成分を含有する皮膚・頭皮・頭髪剤 |
JP3133095B2 (ja) | 1990-04-25 | 2001-02-05 | 兆岐 史 | 消化器病変組織の硬化剤 |
JP2704783B2 (ja) | 1990-05-23 | 1998-01-26 | 長谷川香料株式会社 | 飲食品のフレーバー劣化防止方法 |
CN1028604C (zh) | 1990-06-13 | 1995-05-31 | 成都中医学院 | 一种中药鲜竹沥的制备方法 |
US5585371A (en) | 1990-08-29 | 1996-12-17 | Humanetics Corporation | Treatment of immune system with Δ5-androstenes |
US5096701A (en) * | 1990-12-18 | 1992-03-17 | The Procter & Gamble Company | Oral compositions |
EP0661966B1 (de) | 1991-12-17 | 2000-07-19 | Biovail Technologies Ltd. | Zusammensetzung und verfahren zur ulcusprävention und -behandlung |
JPH05271088A (ja) | 1991-12-27 | 1993-10-19 | Ruibosuteii Japan:Kk | 皮膚疾患・免疫反応による組織障害改善治療剤 |
FR2687572B1 (fr) | 1992-02-26 | 1995-06-09 | Oreal | Utilisation de certains flavonouides dans des compositions cosmetiques, et procede de protection de la peau, ses phaneres et des compositions cosmetiques. |
JPH05331061A (ja) | 1992-06-01 | 1993-12-14 | Tsumura & Co | アポトーシス誘起剤 |
JPH05331161A (ja) | 1992-05-27 | 1993-12-14 | Tsumura & Co | クロモン誘導体及び該化合物を有効成分とするアルドー スリダクターゼ阻害剤 |
US5605929A (en) | 1992-05-27 | 1997-02-25 | Arch Development Corp. | Methods and compositions for inhibiting 5α-reductase activity |
JPH08104268A (ja) | 1992-07-23 | 1996-04-23 | Joji Maruyama | 自転車の駐輪装置 |
US5650432A (en) | 1995-03-24 | 1997-07-22 | Jlb, Inc. | Method of treating or preventing non-viral microbial infection |
US5320830A (en) * | 1992-12-30 | 1994-06-14 | The Procter & Gamble Company | Oral compositions |
US5364845C1 (en) | 1993-03-31 | 2002-09-10 | Nutramax Lab Inc | Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue |
JPH0710768A (ja) | 1993-05-24 | 1995-01-13 | Suntory Ltd | マメ科植物抽出物を有効成分とするヒアルロニダーゼ阻害剤 |
CN1096680A (zh) | 1993-06-19 | 1994-12-28 | 金赞星 | 治疗脑血管病的药 |
JP3529811B2 (ja) | 1993-06-30 | 2004-05-24 | 三省製薬株式会社 | 皮膚外用剤 |
CN1093914A (zh) | 1993-07-04 | 1994-10-26 | 钟定铨 | 万应喉风散及其制造方法 |
JPH0725761A (ja) | 1993-07-09 | 1995-01-27 | Kureha Chem Ind Co Ltd | 軟骨保護剤 |
GB9317071D0 (en) | 1993-08-17 | 1993-09-29 | Univ Strathclyde | Flavonoids |
CN1101856A (zh) * | 1993-10-20 | 1995-04-26 | 宋海 | 一种治疗烧、烫伤的中药烫可喷 |
JP3811198B2 (ja) | 1993-11-17 | 2006-08-16 | 株式会社創研 | 米からの抗アレルギー剤 |
JP3222672B2 (ja) | 1993-12-16 | 2001-10-29 | 三井農林株式会社 | タンパク質合成阻害剤 |
CN1043406C (zh) | 1993-12-27 | 1999-05-19 | 尚庆英 | 复方清带散的制备方法 |
JPH07223941A (ja) * | 1994-02-14 | 1995-08-22 | Nippon Ham Kk | 抗補体作用物質 |
JP3412228B2 (ja) | 1994-02-23 | 2003-06-03 | 松下電器産業株式会社 | ガス遮断装置 |
JPH07242555A (ja) | 1994-03-08 | 1995-09-19 | Suntory Ltd | グルコシルトランスフェラーゼ阻害剤およびこれを有効成分として含有する抗う蝕剤並びに抗う蝕性食品 |
JP2711630B2 (ja) | 1994-04-07 | 1998-02-10 | 株式会社大阪薬品研究所 | 皮膚外用剤 |
DE69530926T2 (de) | 1994-06-30 | 2004-05-19 | Kyowa Hakko Kogyo Co., Ltd. | Mittel zur förderung des haarwachstums |
TW235922B (en) | 1994-07-06 | 1994-12-11 | Amboo Devise Co Ltd | A production process of deodorant |
JPH0826969A (ja) | 1994-07-15 | 1996-01-30 | Osaka Yakuhin Kenkyusho:Kk | 化粧料組成物 |
KR960003725A (ko) | 1994-07-16 | 1996-02-23 | 신국현 | 황금의 후라보노이드 성분으로 된 백내장 치료제 |
JPH08104628A (ja) * | 1994-10-04 | 1996-04-23 | Sumitomo Pharmaceut Co Ltd | マトリックスメタロプロテアーゼ阻害剤 |
US5545411A (en) | 1994-12-16 | 1996-08-13 | Bristol-Myers Squibb Company | Method for lowering viscosity by use of gum acacia |
KR960040370A (ko) | 1995-05-01 | 1996-12-17 | 강상모 | 알콜 장해 예방 및 치료제 조성물 |
US5589160A (en) | 1995-05-02 | 1996-12-31 | The Procter & Gamble Company | Dentifrice compositions |
CA2175985A1 (en) | 1995-05-10 | 1996-11-11 | Yoichi Kiyosuke | Pharmaceutical composition containing substance inhibiting hsp47 production |
JP3488325B2 (ja) | 1995-09-28 | 2004-01-19 | 株式会社大和生物研究所 | 笹茶及びその製造方法 |
GB2306321A (en) * | 1995-10-24 | 1997-05-07 | Anne Child | The use of (+)-catechin in the treatment or prophylaxis of connective tissue disorders |
JPH09227374A (ja) | 1996-02-28 | 1997-09-02 | Taiyo Kagaku Co Ltd | ストレスタンパク質産生抑制組成物 |
AU742198B2 (en) | 1996-04-02 | 2001-12-20 | Mars, Incorporated | Cocoa extract compounds and methods for making and using the same |
JPH09278662A (ja) | 1996-04-10 | 1997-10-28 | Nof Corp | 抗アレルギー剤 |
JPH1025238A (ja) | 1996-07-10 | 1998-01-27 | Mikimoto Pharmaceut Co Ltd | 皮膚外用剤 |
US5773014A (en) * | 1996-10-07 | 1998-06-30 | Bioetica, Inc. | Compositions and methods for inhibiting the formation of unwanted skin pigmentation |
JPH10130162A (ja) | 1996-10-31 | 1998-05-19 | Kanebo Ltd | ヒアルロン酸分解阻害剤、ヒアルロン酸異常分解疾患治療剤および化粧料 |
US5817299A (en) | 1996-11-01 | 1998-10-06 | E-L Management Corp. | Non-chemical sunscreen composition |
JP3213557B2 (ja) | 1996-11-18 | 2001-10-02 | 三井農林株式会社 | 茶カテキンを有効成分として含有する尖圭コンジローマ治療剤 |
US5968973A (en) | 1996-11-18 | 1999-10-19 | Cancer Institute (Hospital), Chinese Academy Of Medical Sciences | Method for treating hyperplasia |
US6197808B1 (en) | 1996-11-18 | 2001-03-06 | Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences | Methods for treating hyperplasia |
JPH10167960A (ja) | 1996-12-12 | 1998-06-23 | Les-Bell:Kk | 肝細胞ガン再発抑制剤 |
JPH10182415A (ja) | 1996-12-20 | 1998-07-07 | Rashieru Seiyaku Kk | 化粧料組成物 |
US5804168A (en) * | 1997-01-29 | 1998-09-08 | Murad; Howard | Pharmaceutical compositions and methods for protecting and treating sun damaged skin |
CN1189365A (zh) | 1997-01-31 | 1998-08-05 | 雷学军 | 抗艾滋病病毒、梅毒螺旋体、淋菌、滴虫的药物 |
US5962517A (en) | 1997-01-31 | 1999-10-05 | Murad; Howard | Pharmaceutical compositions and methods for treating acne |
IN186803B (de) | 1997-02-05 | 2001-11-10 | Panacea Biotec Ltd | |
GB9704904D0 (en) | 1997-03-10 | 1997-04-30 | Riley Fletcher Foundation The | Essential oil composition |
US5766614A (en) * | 1997-03-20 | 1998-06-16 | Yong; Liu | Burn treatment compositions containing herbal mix |
WO1998042363A1 (fr) | 1997-03-21 | 1998-10-01 | Shiseido Company, Ltd. | Immunostimulants |
JPH10287528A (ja) | 1997-04-07 | 1998-10-27 | Rashieru Seiyaku Kk | 化粧料組成物 |
JP4231559B2 (ja) | 1997-04-23 | 2009-03-04 | オリザ油化株式会社 | リポキシゲナーゼ阻害剤 |
PL187310B1 (pl) | 1997-04-29 | 2004-06-30 | Antoni Gwardys | Naturalny preparat przeciwutleniający |
US6243841B1 (en) * | 1997-05-30 | 2001-06-05 | Texas Instruments Incorporated | Automated test and evaluation sampling system and method |
US5886155A (en) * | 1997-06-18 | 1999-03-23 | Bioresources International Inc. | Purification of miraculin glycoprotein using tandem hydrophobic interaction chromatography |
IN1997DE01715A (de) | 1997-06-24 | 2015-07-31 | Council Scient Ind Res | |
US6093403A (en) * | 1997-08-01 | 2000-07-25 | Phytocell Research, Inc. | Sugar imbalance and diabetes treating herbal formulation |
KR19990015612A (ko) * | 1997-08-07 | 1999-03-05 | 한영복 | 황백피와 마타리 식물의 혼합추출물을 함유하는 c형 간염 치료제조성물 |
US5886029A (en) * | 1997-09-05 | 1999-03-23 | Dhaliwal; Kirpal S. | Method and composition for treatment of diabetes |
JP2001507198A (ja) | 1997-10-02 | 2001-05-29 | 株式会社ニッコー | 移動通信機器から送信された電波を遮蔽する装置 |
CN1062753C (zh) | 1997-10-21 | 2001-03-07 | 陈新学 | 防治眼睛疾病的药物 |
US6696484B2 (en) | 1997-10-31 | 2004-02-24 | University Of Chicago Office Of Technology And Intellectual Property | Method and compositions for regulation of 5-alpha reductase activity |
US6576660B1 (en) * | 1997-10-31 | 2003-06-10 | Arch Development Corporation | Methods and compositions for regulation of 5-α-reductase activity |
JPH11140497A (ja) | 1997-10-31 | 1999-05-25 | Amyuure:Kk | カテキン入り石鹸 |
WO1999023077A1 (en) * | 1997-11-04 | 1999-05-14 | Pfizer Products Inc. | Indazole bioisostere replacement of catechol in therapeutically active compounds |
US6221341B1 (en) * | 1997-11-19 | 2001-04-24 | Oraceutical Llc | Tooth whitening compositions |
US6083921A (en) | 1998-01-12 | 2000-07-04 | Xu; Kai Jian | Pharmaceutical compositions and method of using same |
US5922756A (en) | 1998-02-14 | 1999-07-13 | Chan; Marion Man-Ying | Method of inhibiting nitric oxide synthase |
CN1066055C (zh) | 1998-03-17 | 2001-05-23 | 浙江农业大学 | 从竹叶中提取黄酮类化合物浸膏或粉剂的生产方法 |
US5908628A (en) * | 1998-05-01 | 1999-06-01 | Hou; Liping | Compositions with analgesic, antipyretic and antiinflammatory properties |
EP0956867A1 (de) * | 1998-05-12 | 1999-11-17 | Franz-Peter Dr. Liebel | Verwendung von Flavonoidglykosiden, Gerbstoffen und Mikroorganismen zur Therapie und Prophylaxe des Diabetes mellitus |
FR2778663B1 (fr) | 1998-05-15 | 2001-05-18 | Coletica | Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire |
US6043694A (en) | 1998-06-24 | 2000-03-28 | Siemens Aktiengesellschaft | Lock arrangement for a calibrated DLL in DDR SDRAM applications |
JP2000044481A (ja) | 1998-07-30 | 2000-02-15 | Sunstar Inc | 皮膚外用剤 |
US6080401A (en) | 1998-11-19 | 2000-06-27 | Reddy; Malireddy S. | Herbal and pharmaceutical drugs enhanced with probiotics |
JP4507027B2 (ja) * | 1998-12-04 | 2010-07-21 | 明治乳業株式会社 | Mmp阻害剤 |
US6194469B1 (en) * | 1998-12-11 | 2001-02-27 | Board Of Trustees Operating Michigan State Univeristy | Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids |
US20020098207A1 (en) * | 1999-02-08 | 2002-07-25 | Daniel H. Maes | Cholesterol sulfate compositions for enhancement of stratum corneum function |
US6264926B1 (en) * | 1999-02-12 | 2001-07-24 | Council Of Scientific And Industrial Research | Formulation useful as a natural herbal tooth powder |
US6241972B1 (en) * | 1999-02-19 | 2001-06-05 | Block Drug Company, Inc. | Oral care formulation for the treatment of sensitivity teeth |
KR100317112B1 (ko) * | 1999-03-18 | 2001-12-22 | 한영복 | 지모와 황백피의 혼합 수추출물을 포함하는 염증 및 통증 치료용조성물 및 그 제조 방법 |
EP1093376A1 (de) | 1999-04-08 | 2001-04-25 | Metagenics, Inc. | Zusammensetzung und methode zur behandlung von entzündungen und schmerz in säugetieren |
US6333304B1 (en) | 1999-04-20 | 2001-12-25 | Teresa K. Bath | Therapeutic compositions containing glucosamine, collagen and a bioflavanol for repair and maintenance of connective tissue |
WO2000067749A1 (en) | 1999-05-05 | 2000-11-16 | Unilever N.V. | Food product |
JP4082823B2 (ja) | 1999-05-06 | 2008-04-30 | 日本メナード化粧品株式会社 | 光毒性抑制剤 |
JP4521894B2 (ja) * | 1999-05-28 | 2010-08-11 | 明治乳業株式会社 | マトリックスメタロプロテアーゼ阻害剤 |
EP1207862A2 (de) * | 1999-06-07 | 2002-05-29 | The University Of Sheffield | Arthritisbehandlung |
KR20010017481A (ko) | 1999-08-11 | 2001-03-05 | 신상국 | 여드름 제거용 음료 조성물 및 그 제조방법 |
JP2001187744A (ja) | 1999-10-19 | 2001-07-10 | Tasuku Okuda | 細胞活性化剤及びこれを用いた製品 |
US6264995B1 (en) | 1999-10-19 | 2001-07-24 | Thomas Newmark | Herbal composition for reducing inflammation and methods of using same |
AU7957000A (en) | 1999-10-25 | 2001-05-08 | Japan As Represented By Director General Of Agency Of National Cancer Center | Cyclooxygenase-2 expression inhibitors |
KR100390639B1 (ko) | 2000-01-12 | 2003-07-07 | 김미정 | 대나무 잎 추출물을 유효성분으로 첨가한 식품조성물의 제조방법 |
US6248341B1 (en) | 2000-01-14 | 2001-06-19 | Color Access, Inc. | Method of treating topical angiogenesis-related disorders |
JP2001220353A (ja) | 2000-02-07 | 2001-08-14 | Noevir Co Ltd | ホスフォリパーゼa2阻害剤 |
US6290995B1 (en) | 2000-02-08 | 2001-09-18 | Zhao Xinxian | Plant drug for preventing cancer II |
KR100364383B1 (ko) * | 2000-02-10 | 2002-12-18 | 김호철 | 신경보호작용을 갖는 황금추출물 및 이를 함유하는 약학적제제 |
EP1127572A3 (de) | 2000-02-25 | 2003-05-02 | Basf Aktiengesellschaft | Verwendung von Flavonen zur Behandlung von Cyclooxygenase-2 ermittelten Krankheiten |
US20020086070A1 (en) | 2000-03-11 | 2002-07-04 | Kuhrts Eric Hauser | Anti-inflammatory and connective tissue repair formulations |
CN1436074A (zh) | 2000-04-11 | 2003-08-13 | 宝生物工程株式会社 | 治疗剂 |
US20030170186A1 (en) | 2000-04-18 | 2003-09-11 | Bernadette Geers | Novel flavone glycoside derivatives for use in cosmetics, pharmaceuticals and nutrition |
EP1147764A3 (de) | 2000-04-19 | 2002-03-20 | Nof Corporation | Kosmetische Zusammensetzung |
US6475530B1 (en) | 2000-05-31 | 2002-11-05 | Eric H. Kuhrts | Methods and compositions for producing weight loss |
JP4719372B2 (ja) | 2000-06-21 | 2011-07-06 | 花王株式会社 | Ppar依存的遺伝子転写活性化剤 |
US6319523B1 (en) | 2000-06-29 | 2001-11-20 | James H. Zhou | Composition and method for inhibiting oral bacteria |
AU2001267917A1 (en) | 2000-07-26 | 2002-02-05 | Kenjirou Tsuchida | Antipruritic compositions and compositions promoting wound healing |
MXPA03000848A (es) | 2000-07-28 | 2004-12-13 | Immupharm Aps | Metodos para el tratamiento de sintomas del resfriado comun, rinitis alergica e infecciones relacionadas con el tracto respiratorio. |
JP2002053484A (ja) * | 2000-08-07 | 2002-02-19 | Asahi Breweries Ltd | リパーゼ阻害剤およびそれを含む飲食品 |
KR100417791B1 (ko) | 2000-08-14 | 2004-02-11 | 미즈코리아 주식회사 | 항균 및 미용기능을 갖는 생약추출물과 이를 함유한 제품 |
CN1285202A (zh) | 2000-08-26 | 2001-02-28 | 田积天 | 火清正阳帖 |
KR20020031608A (ko) | 2000-10-19 | 2002-05-03 | 이응세 | 항균효과가 우수한 황금 추출물, 그의 제조방법 및 그를포함하는 약학적 조성물 |
WO2002042429A2 (en) | 2000-11-03 | 2002-05-30 | Proteotech, Inc. | Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
FR2816839B1 (fr) | 2000-11-20 | 2003-09-26 | Schwartz Laboratoires Robert | Produit preparant et protegeant la peau contre les rayons uv, agissant a l'encontre du vieillissement cellulaire et excercant une action immunostimulante |
CA2431044A1 (en) | 2000-12-13 | 2002-06-20 | University Of Rochester | Oral compositions and use thereof |
US20020122836A1 (en) | 2000-12-15 | 2002-09-05 | Pharmacia Corporation | Selective COX-2 inhibition from non-edible plant extracts |
AU2002229074A1 (en) | 2000-12-15 | 2002-06-24 | Pharmacia Corporation | Selective cox-2 inhibition from plant extracts |
US6555573B2 (en) * | 2000-12-21 | 2003-04-29 | The Quigley Corporation | Method and composition for the topical treatment of diabetic neuropathy |
US20020146467A1 (en) | 2001-02-08 | 2002-10-10 | Jung Kyu Yong | Herbal composition for the prevention and treatment of dementia |
US6387416B1 (en) | 2001-04-05 | 2002-05-14 | Thomas Newmark | Anti-Inflammatory herbal composition and method of use |
US6391346B1 (en) | 2001-04-05 | 2002-05-21 | Thomas Newmark | Anti-inflammatory, sleep-promoting herbal composition and method of use |
JP4901025B2 (ja) | 2001-06-22 | 2012-03-21 | 株式会社ナリス化粧品 | エラスターゼ阻害剤 |
KR20040010776A (ko) | 2001-06-27 | 2004-01-31 | 유니젠 파아마슈티컬스,인크. | 치료제 발견을 위해 천연산물 라이브러리를 제조, 선별 및데레플리케이션하는 방법 |
US6685971B2 (en) * | 2001-06-28 | 2004-02-03 | Rongxiang Xu | Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract |
DE10133203A1 (de) | 2001-07-07 | 2003-01-16 | Beiersdorf Ag | Catechine oder Extrakte von grünem Tee enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut |
CN1395383A (zh) * | 2001-07-10 | 2003-02-05 | 颜森辉 | 智能型全方位专家管理系统 |
DE10139793A1 (de) | 2001-08-14 | 2003-02-27 | Beiersdorf Ag | Verwendung von Wogonin zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter und trockener Haut |
US7338971B2 (en) * | 2001-08-30 | 2008-03-04 | El-Naggar Mawaheb M | Treatment of inflammatory, cancer, and thrombosis disorders |
KR100486763B1 (ko) | 2001-09-07 | 2005-05-03 | 학교법인고려중앙학원 | 항산화 활성이 있는 맹종죽엽 추출물 및 그 제조방법 |
JP2003081746A (ja) | 2001-09-12 | 2003-03-19 | Pola Chem Ind Inc | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 |
WO2003024470A1 (en) | 2001-09-17 | 2003-03-27 | Philip Wolfson | Standardized extracts of scutellaria lateriflora |
US20040185124A1 (en) * | 2002-10-24 | 2004-09-23 | Hiromichi Hayashi | Health food and antitumor agent |
US20040057908A1 (en) * | 2001-12-13 | 2004-03-25 | Bowen William H. | Oral compositions and use thereof |
US20030125264A1 (en) * | 2001-12-29 | 2003-07-03 | Kimberly-Clark Worldwide, Inc. | Methods For Treating Wounds |
JP2003212786A (ja) | 2002-01-16 | 2003-07-30 | Univ Nihon | 竹の抽出成分を有効成分とする皮膚外用薬 |
JP2003212771A (ja) | 2002-01-23 | 2003-07-30 | Taiyo Kagaku Co Ltd | 抗ナイセリア菌組成物 |
US20030166583A1 (en) * | 2002-02-22 | 2003-09-04 | Oliver Yoa-Pu Hu | Dermal cytochrome P450 1A inhibitors and enhancers |
US7972632B2 (en) | 2003-02-28 | 2011-07-05 | Unigen Pharmaceuticals, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
US7108868B2 (en) | 2002-03-22 | 2006-09-19 | Unigen Pharmaceuticals, Inc. | Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
US20030165588A1 (en) | 2002-03-01 | 2003-09-04 | Unigen Pharmaceuticals, Inc. | Identification of free-B-ring flavonoids as potent COX-2 inhibitors |
JP4294495B2 (ja) | 2002-04-15 | 2009-07-15 | 哲夫 山東 | 皮膚炎治療薬 |
US8945518B2 (en) * | 2002-04-30 | 2015-02-03 | Unigen, Inc. | Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions |
NZ535988A (en) | 2002-04-30 | 2005-09-30 | Unigen Pharmaceuticals Inc | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
US8034387B2 (en) * | 2002-04-30 | 2011-10-11 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
CN1511549A (zh) | 2002-12-27 | 2004-07-14 | 张小丽 | 含有黄芩的抗肿瘤、抗炎症及肿瘤预防药物的组合物 |
JP2004244385A (ja) | 2003-02-14 | 2004-09-02 | Pigeon Corp | 防齲蝕性を有する乳幼児用の口腔内洗浄液 |
CA2516710A1 (en) | 2003-02-26 | 2004-09-10 | Unigen Pharmaceuticals, Inc. | Formulation for use in the prevention and treatment of carbohydrate induced diseases and conditions |
US20060078632A1 (en) * | 2003-03-27 | 2006-04-13 | Unigen, Inc. | Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease |
CA2521429A1 (en) | 2003-04-04 | 2004-10-21 | Unigen Pharmaceuticals, Inc. | Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care |
US7225870B2 (en) * | 2003-05-01 | 2007-06-05 | Weatherford/Lamb, Inc. | Hydraulic tools for setting liner top packers and method for cementing liners |
CN1266144C (zh) * | 2003-09-01 | 2006-07-26 | 上海凯曼生物科技有限公司 | 黄芩甙和黄芩甙元的用途和剂型 |
RU2392957C2 (ru) * | 2003-09-02 | 2010-06-27 | Юниджен Фармасьютиклз, Инк. | Композиция, содержащая смесь флавоноидов со свободным кольцом и флаванов, которая предназначена для предупреждения и лечения ухудшения когнитивной способности и связанных с возрастом ослаблений памяти |
EP1684737A4 (de) * | 2003-11-07 | 2009-11-11 | Oaky Natural Co Ltd | Pharmazeutische zusammensetzung mit guaiacol-derivaten und syringol-derivaten extrahiert aus natürlichem pflanzlichem essig |
KR100465113B1 (ko) | 2004-01-15 | 2005-01-14 | 주식회사 유니젠 | 대나무 추출물 또는 이로부터 분리된 트리신을 포함하는조성물 |
KR100522579B1 (ko) | 2004-04-30 | 2005-10-19 | (주) 한약마을 | 항스트레스 효과를 갖는 황금 및 오미자 혼합 추출물을함유하는 약학조성물 |
KR100720971B1 (ko) | 2004-06-11 | 2007-05-22 | 주식회사 유니젠 | 대나무 또는 대나무 추출물을 포함하는 안드로젠 효능성조성물 |
US20060008749A1 (en) * | 2004-07-08 | 2006-01-12 | Frank Sobel | Method for manufacturing of a mask blank for EUV photolithography and mask blank |
KR100545304B1 (ko) | 2004-09-01 | 2006-05-08 | 주식회사 유니젠 | 아선약을 포함하는 운카리아 속 식물, 또는 이의 황금및/또는 녹차의 배합물을 포함하는 사이클로옥시게나제및/또는 5-리폭시게나제 억제용 조성물 |
US20060140881A1 (en) * | 2004-12-22 | 2006-06-29 | Guofeng Xu | Oral care compositions containing flavonoids and flavans |
US8895084B2 (en) * | 2004-12-23 | 2014-11-25 | Colgate-Palmolive Company | Oral care composition containing extract of unoxidized Camellia |
EP2444093A1 (de) | 2005-03-10 | 2012-04-25 | Unigen, Inc. | Formulierung einer Mischung aus Flavonoiden mit freiem B-Ring und Flavanen als Therapiemittel |
KR100720973B1 (ko) * | 2005-03-18 | 2007-05-22 | 주식회사 유니젠 | 천연물 유래 아이소오리엔틴을 포함하는 히스타민 억제용약학 조성물 |
CN1686187A (zh) | 2005-03-23 | 2005-10-26 | 贵阳高新瑞得科技开发有限公司 | 小儿清肺化痰泡腾颗粒及其制法 |
KR100761248B1 (ko) | 2006-10-12 | 2007-10-04 | 주식회사 유니젠 | 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물 |
US9136202B2 (en) | 2012-04-17 | 2015-09-15 | Qualcomm Incorporated | Enhanced package thermal management using external and internal capacitive thermal material |
US10447702B2 (en) | 2017-03-20 | 2019-10-15 | Screening Room Media, Inc. | Digital credential tiers |
-
2003
- 2003-04-30 NZ NZ535988A patent/NZ535988A/en not_active IP Right Cessation
- 2003-04-30 RU RU2004135069/15A patent/RU2379031C2/ru not_active IP Right Cessation
- 2003-04-30 EP EP09167112A patent/EP2108370A1/de not_active Withdrawn
- 2003-04-30 KR KR1020037008922A patent/KR100621234B1/ko active IP Right Grant
- 2003-04-30 CN CNB038098210A patent/CN100544715C/zh not_active Expired - Lifetime
- 2003-04-30 CN CN2009101641172A patent/CN101837003B/zh not_active Expired - Lifetime
- 2003-04-30 CA CA2484192A patent/CA2484192C/en not_active Expired - Lifetime
- 2003-04-30 BR BRPI0309689-0A patent/BRPI0309689B1/pt not_active IP Right Cessation
- 2003-04-30 US US10/427,746 patent/US7514469B2/en active Active
- 2003-04-30 ES ES03726548T patent/ES2330097T3/es not_active Expired - Lifetime
- 2003-04-30 DE DE60328676T patent/DE60328676D1/de not_active Expired - Lifetime
- 2003-04-30 WO PCT/US2003/013463 patent/WO2003092599A2/en not_active Application Discontinuation
- 2003-04-30 AT AT03726548T patent/ATE438393T1/de not_active IP Right Cessation
- 2003-04-30 DK DK03726548T patent/DK1503778T3/da active
- 2003-04-30 AU AU2003228777A patent/AU2003228777C1/en not_active Expired
- 2003-04-30 JP JP2004500784A patent/JP4723239B2/ja not_active Expired - Fee Related
- 2003-04-30 EP EP03726548A patent/EP1503778B1/de not_active Expired - Lifetime
- 2003-04-30 CA CA2703698A patent/CA2703698C/en not_active Expired - Lifetime
- 2003-06-13 US US10/462,030 patent/US7674830B2/en active Active
-
2005
- 2005-07-12 HK HK05105928.1A patent/HK1073247A1/xx not_active IP Right Cessation
-
2006
- 2006-04-17 US US11/279,925 patent/US9655940B2/en active Active
-
2010
- 2010-11-29 JP JP2010264570A patent/JP2011068662A/ja not_active Withdrawn
-
2011
- 2011-01-27 HK HK11100877.5A patent/HK1146712A1/xx not_active IP Right Cessation
-
2013
- 2013-11-12 US US14/078,053 patent/US9370544B2/en not_active Expired - Lifetime
-
2016
- 2016-06-17 US US15/186,113 patent/US9849152B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE438393T1 (de) | Formulierung eines gemisches aus flavonoiden und flavanen mit freiem b ring als therapeutisches mittel | |
EA200800157A1 (ru) | Антагонисты npy, способ их получения и применение | |
WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
NO20053077L (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
TW200612926A (en) | Compounds and compositions as ppar modulators | |
BR0213540A (pt) | Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos | |
BRPI0414455A (pt) | métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins | |
TW200806318A (en) | Uses of anti-insulin-like growth factor I receptor antibodies | |
MXPA06001193A (es) | Compuestos de indazol 3,5-disustituidos, composiciones farmaceuticas y metodos para intervenir en o inhibir la proliferacion celular. | |
WO2005070081A3 (en) | Methods of using zonisamide as an adjunctive therapy for partial seizures | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
WO2003032994A3 (de) | 5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren | |
IL171607A (en) | Use of botulinum toxin for the treatment of sinusitis-induced headaches | |
TW200600505A (en) | Compounds and compositions as ppar modulators | |
WO2005103687A3 (en) | System and method for providing optimal concentrations for medication infusions | |
TNSN06403A1 (en) | 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF | |
MX2008001520A (es) | Composiciones de tizanidina y metodos de tratamiento usando las composiciones. | |
WO2005070079A3 (en) | Methods of using zonisamide as an adjunctive therapy for partial seizures | |
WO2007134326A3 (en) | Methods for treating autoimmune diseases using a taci-ig fusion molecule | |
WO2005070078A3 (en) | Methods of using zonisamide as an adjunctive therapy for partial seizures | |
WO2005070077A3 (en) | Methods of using zonisamide as an adjunctive therapy for partial seizures | |
WO2002070741A3 (en) | Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna | |
AU2003271807A8 (en) | Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same | |
TW200517119A (en) | Method of treatment using interferon-tau | |
WO2005056520A8 (en) | Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
R082 | Change of representative |
Ref document number: 1503778 Country of ref document: EP Representative=s name: DF-MP, 80333 MUENCHEN, DE |